Search Tag: cell therapies
2022 09 Dec
Dr. Borrello is an internationally recognized physician-scientist focusing on developing novel cell-based therapies and transplant platforms for patients with multiple myeloma and other malignancies. Tampa General Hospital is announcing its appointment of Dr. Ivan Borrello to the TGH Cancer Institute. Borrello is a world-class translational...Read more
2022 21 Sep
Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today named Rutul R. Shah as the Company's Chief Operating Officer (COO), effective October 1, 2022. Mr. Shah has been with the Company since 2014 and has served in roles of increasing responsibility...Read more